Both FTLD-tau and FTLD-TDP data sets were enriched for gene sets previously associated with Alzheimer’s disease and Huntington’s disease, suggesting dysregulated pathways common to neurodegenerative conditions, next to gene sets associated with oxidative phosphorylation (Fig. 4). This evidence concerns the gene MAPT and Alzheimer disease.